CD4 and pemphigus foliaceus: Although there were no differences in CD4+ Tconv frequencies at baseline and week 3 in PF and PD, we observed a higher frequency of CD4+ Tconv in PF compared with PD at week 6—a later on-treatment time point (Fig. 5A), suggesting persisting CD4+ T cell responses in PF patients over time.